Vascular Biology and Metabolism (VAM)

< Back

Overview

The VAM area was created to allow a comprehensive, cooperative and multidisciplinary approach in basic, clinical and epidemiology research. The ultimate goal is the innovation and transfer of solutions in a group of diseases that are closely interrelated and that constitute the leading cause of morbidity and mortality in the world: cardio-cerebrovascular disease, diabetes-metabolic syndrome and renal impairment. The VAM area includes preclinical and clinical research staff from our center, and collaborative work with groups of the highest international prestige. VAM area includes 8 groups: Cardiovascular Pathology, Diabetes and Metabolism, Nephrology, Ophthalmology (focused on retinal vascular disease), CIBBIM-Nanomedicine and Kidney Physiopathology, Medical Molecular Imaging, Neurovascular Diseases, and Research on Aging, Frailty and Transitions in Barcelona. All groups use an integrative tridimensional approach to generate knowledge on the mechanisms of diseases to generate new diagnostic and therapeutic tools.

Publications

248
total
1470
impact factor
5.93
average impact factor

Group Leaders: Castell Conesa, Joan and Herance Camacho, José Raul

group-team team group-zoom zoom group-download download

Research Areas

The highlights of the Medical Molecular Imaging research group in 2019 were:

  1. The ImmuneImage project to develop several PET radiopharmaceuticals to detect immune cells populations in vivo to apply in the development of immunotherapies has start in October.
  2. The new isotopic therapy unit was become a national reference unit to treat oncological patients, teach professionals and research. Therefore, several clinical trials were performed mainly focused on the development of new theranostic agents to apply in NET and prostate tumours. In addition, some teaching courses were done.
  3. We have finished the clinical trial focused on phenotyping organ-specific insulin sensibility in type 2 diabetic patients by 18F-FDG PET/CT to go ahead with this research line
  4. Several studies focused on infectious endocarditis have performed and published during this period
  5. New PET/CT diagnostic approaches based on commercials radiopharmaceuticals have performed for tuberculosis

VHIR Annual Report 2019

© FIR-HUVH Fundació Institut de Recerca Hospital Universitari Vall d’Hebron 2019 | Developed by: ondeuev